A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
Owen, Dwight H, Benner, Brooke, Wei, Lai, Sukrithan, Vineeth, Goyal, Ashima, Zhou, Ye, Pilcher, Carly, Suffren, Sheryl-Ann, Christenson, Gwen, Curtis, Nancy, Jukich, Megan, Schwarz, Emily, Savardekar, Himanshu, Norman, Ruthann, Ferguson, Sarah, Kleiber, Barbara, Wesolowski, Robert, Carson, William E, Otterson, Gregory A, Verschraegen, Claire F, Shah, Manisha H, Konda, Bhavana
Published in Clinical cancer research (16.02.2023)
Published in Clinical cancer research (16.02.2023)
Get full text
Journal Article
Efficacy of nivolumab and temozolomide in advanced neuroendocrine neoplasms (NENs) in a phase 2 clinical trial
Owen, Dwight Hall, Benner, Brooke, Wei, Lai, Sukrithan, Vineeth, Goyal, Ashima, Zhou, Ye, Suffren, Sheryl-Ann, Pilcher, Carly, Christenson, Gwen, Curtis, Nancy, Savardekar, Himanshu, Norman, Ruthann, Ferguson, Sarah, Kleiber, Barbara, Wesolowski, Robert, Carson, William Edgar, Otterson, Gregory Alan, Verschraegen, Claire F., Shah, Manisha H., Konda, Bhavana
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Association of LAG-3 expression in circulating T cells and response to combination temozolomide (TMZ) and nivolumab (NIVO) in advanced neuroendocrine neoplasms (NENs): Results from an investigator-initiated phase 2 trial
Sukrithan, Vineeth, Benner, Brooke, Wei, Lai, Goyal, Ashima, Zhou, Ye, Suffren, Sheryl-Ann, Pilcher, Carly, Christenson, Gwen, Curtis, Nancy, Schwarz, Emily, Savardekar, Himanshu, Norman, Ruthann, Kleiber, Barbara, Wesolowski, Robert, Otterson, Gregory Alan, Verschraegen, Claire F., Carson, William Edgar, Shah, Manisha H., Konda, Bhavana, Owen, Dwight Hall
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article